help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Biophysical Journal 67: 2316-2325 (1994)
© 1994 the Biophysical Society

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shieh, C C
Right arrow Articles by Kirsch, G E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shieh, C C
Right arrow Articles by Kirsch, G E

Mutational analysis of ion conduction and drug binding sites in the inner mouth of voltage-gated K+ channels.

C C Shieh and G E Kirsch

Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030.

ABSTRACT

Pore properties that distinguish two cloned, voltage-gated K+ channels, Kv2.1 and Kv3.1, include single-channel conductance, block by external and internal tetraethylammonium, and block by 4-aminopyridine. To define the inner mouth of voltage-gated K+ channels, segmental exchanges and point mutations of nonconserved residues were used. Transplanting the cytoplasmic half of either transmembrane segments S5 or S6 from Kv3.1 into Kv2.1 reduced sensitivity to block by internal tetraethylammonium, increased sensitivity to 4-aminopyridine, and reduced single-channel conductance. In S6, changes in single-channel conductance and internal tetraethylammonium sensitivity were associated with point mutations V400T and L403 M, respectively. Although individual residues in both S5 and S6 were found to affect 4-aminopyridine blockade, the most effective change was L327F in S5. Thus, both S5 and S6 contribute to the inner mouth of the pore but different residues regulate ion conduction and blockade by internal tetraethylammonium and 4-aminopyridine.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
D. L. B. Winkelman, C. L. Beck, D. L. Ypey, and M. E. O'Leary
Inhibition of the A-Type K+ Channels of Dorsal Root Ganglion Neurons by the Long-Duration Anesthetic Butamben
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1177 - 1186.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. C. M. Choisy, J. C. Hancox, L. A. Arberry, A. M. Reynolds, M. J. Shattock, and A. F. James
Evidence for a Novel K+ Channel Modulated by {alpha}1A-Adrenoceptors in Cardiac Myocytes
Mol. Pharmacol., September 1, 2004; 66(3): 735 - 748.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
S. M. Cibulsky and W. A. Sather
Control of Ion Conduction in L-type Ca2+ Channels by the Concerted Action of S5-6 Regions
Biophys. J., March 1, 2003; 84(3): 1709 - 1719.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. I. V. Judge, J. Z. Yeh, J. E. Goolsby, M. J. Monteiro, and C. T. Bever Jr.
Determinants of 4-Aminopyridine Sensitivity in a Human Brain Kv1.4 K+ Channel: Phenylalanine Substitutions in Leucine Heptad Repeat Region Stabilize Channel Closed State
Mol. Pharmacol., April 1, 2002; 61(4): 913 - 920.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
C.-C. Shieh, M. Coghlan, J. P. Sullivan, and M. Gopalakrishnan
Potassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities
Pharmacol. Rev., December 1, 2000; 52(4): 557 - 594.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. P. Lees-Miller, Y. Duan, G. Q. Teng, and H. J. Duff
Molecular Determinant of High-Affinity Dofetilide Binding to HERG1 Expressed in Xenopus Oocytes: Involvement of S6 Sites
Mol. Pharmacol., February 1, 2000; 57(2): 367 - 374.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
G.-N. Tseng
Different State Dependencies of 4-Aminopyridine Binding to rKv1.4 and rKv4.2: Role of the Cytoplasmic Halves of the Fifth and Sixth Transmembrane Segments
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 569 - 577.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Zhang, B. Zhu, J.-A. Yao, and G.-N. Tseng
Differential Effects of S6 Mutations on Binding of Quinidine and 4-Aminopyridine to Rat Isoform of Kv1.4: Common Site but Different Factors in Determining Blockers' Binding Affinity
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 332 - 343.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
S. W. Yeola, T. C. Rich, V. N. Uebele, M. M. Tamkun, and D. J. Snyders
Molecular Analysis of a Binding Site for Quinidine in a Human Cardiac Delayed Rectifier K+ Channel : Role of S6 in Antiarrhythmic Drug Binding
Circ. Res., June 1, 1996; 78(6): 1105 - 1114.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
G. H. Hockerman, B. D. Johnson, T. Scheuer, and W. A. Catterall
Molecular Determinants of High Affinity Phenylalkylamine Block of L-type Calcium Channels
J. Biol. Chem., September 22, 1995; 270(38): 22119 - 22122.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Biophysical Society.